SCHEMBL2068331

SCHEMBL2068331

Cc1[c]ccc(N2CC(F)(F)C(F)(F)C2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2068322 0.90 PDE10A (0.31) —
SCHEMBL25308587 0.81 CLK2 (0.36) —
SCHEMBL2068403 0.77 KDM4E (0.40) —
SCHEMBL2067363 0.77 HTR3E (0.37) —
SCHEMBL1819991 0.72 KMT2A (0.46) —
SCHEMBL22529934 0.72 HTR3E (0.47) —
SCHEMBL2068134 0.72 PIM1 (0.33) —
SCHEMBL2069492 0.69 METAP2 (0.39) —
SCHEMBL2068582 0.67 MAP4K4 (0.43) —
SCHEMBL2068155 0.67 PIM1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438063-A1 1H-IMIDAZO[4,5-C]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES Novartis AG (CH) 2012-04-11 — — EP disclosed
WO-2010139747-A1 1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2010-12-09 — — WO disclosed
US-20100311714-A1 1H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS NOVARTIS AG (CH) 2010-12-09 — — US disclosed
Send feedback